On-demand Encore Virtual Sessions

The On-demand Encore Virtual Sessions offer greater flexibility for individual circumstances. The On-demand Encore Virtual Sessions consist of recorded accredited sessions from the live meeting. Take in the sessions 24/7 virtually from your workplace, comfort of your home or any other place of your choosing, starting August 1, 2021 and continuing through December 1, 2021. Registrants can participate in On-demand Encore Virtual Sessions on an a-la-carte basis, or bundle them as a package.

A-la-carte – Select one or more of the 22 On-demand Encore Virtual Sessions, with .75, 1.0 or 1.5 CE hour(s) being offered per session. View the session(s) video and obtain a CE certificate after successfully completing and passing a 6-question test on the session content. The cost is $25 per session. If you are not successful in passing a test, you may review the session video again and retake the same test, at no additional cost. Registration for On-demand Encore Virtual Sessions a-la-carte will open August 1, 2021.

Package – The package will consist of 22 On-demand Encore Virtual Sessions offering up to 29.25 CE hours cumulatively. View the session(s) video and obtain a CE certificate after successfully completing and passing a 6-question test on the session content. The package cost is $400. If you are not successful in passing a test, you may review the session video again and retake the same test, at no additional cost.The On-demand Encore Virtual Sessions Package is a pre-determined package. Substitution of sessions is not available. CLICK HERE to register for the On-demand Encore Virtual Sessions Package.

Notes:

You can register for the On-demand Encore Virtual Sessions (a-la-carte or package) without attending the live meeting in-person.
If you attend the live meeting in-person, and select the a-la-carte add-on option, the first 6 On-demand Encore Virtual Sessions are complimentary, with additional sessions at $25 per session.
CE hours are not allowed to be awarded for duplicate session(s) previously attended at the live meeting in-person.
You do not need to complete everything in one sitting.You can return anytime through and including December 1, 2021 to view additional sessions and/or take tests.
80% correct is considered passing for the 6-question test.

Links to view the session recordings will be posted here starting August 1, 2021. Below are the 22 On-demand Encore Virtual Sessions that will be offered.

Click the column header to sort.
Click a specific title and/or speaker to expand for additional information. Click again to contract the additional infomration.
Search box will display results for matches (if any) of items entered in the search box.

#	Session Code	Title	Speaker	CE Hours	% Rx
1	Pre 2	Dermatology Conundrums: Interesting Cases Rashes and lesions seen in primary care can be confusing. The healthcare provider is responsible for identification of conditions, which must be referred for co-management and those which can be managed within the primary care setting. Mismanagement can exacerbate the condition and make diagnosis more difficult. Through the use of case studies, learn how to accurately describe lesions, provide a differential diagnosis, and which treatment options are available.	Peggy Vernon, RN, MA, C-PNP, DCNP, FAANP Owner/Dermatology Nurse Practitioner, Creekside Skin Care; Greenwood Village CO	1.5 CE hours	50%
2	Pre 3	Hereditary Cancer Risk Assessment and Testing: Evolving Guidelines, Updates and Resources to Support Identification and Management of Patients at Risk Identifying patients at risk for a hereditary cancer syndrome during the annual wellness visit is critical to prevention and early detection of cancer for high-risk patients. With diagnostic and management recommendations for hereditary cancer syndromes in constant flux, staying current may be difficult. Hear about some of the emerging trends in hereditary cancer risk assessment and testing. An update on current National Comprehensive Cancer Network® Guideline will be provided, with highlights of what has changed (and why), and a discussion of what lies ahead. Case studies will be used in this interactive session to identify knowledge gaps and encourage attendees to think critically about enhancements to their current genetic risk assessment and testing approach. Incorporate the evolving guidelines into you current practice and prepare for changes that may be seen in the future.	Amy Cronister, MS Director, Genetic Counseling Services, Integrated Genetics; Phoenix AZ	1.5 CE hours	0%
3	Pre 5	Primary to Acute Care Palliative Care Transitions Palliative Care is a relatively new specialized health field to care for patients and their families who are experiencing a serious illness. Often confused with hospice, palliative care is based on patient and family needs, not prognosis. All hospice care is palliative, yet all palliative care is not hospice. Looking at the history of both and definitions will help clarify the misconceptions that surround these two fields. Palliative Care may be provided in a variety of settings. By focusing on patients symptoms, frequent communication and overall support, quality of life is improved and the need for frequent hospitalizations is reduced. Gain a better understanding of the the benefits associated with early involvement of palliative care.	Janet Leahy, MSN, ACNP-BC, ACHPN Supervisor, Advanced Practice Providers, Hospital and Outpatient Based Palliative Care, University of Pittsburgh Medical Center; Pittsburgh PA	1.0 CE hour	0%
4	Pre 7	Partially Responsive Depressed Patient Are your depressed patients feeling totally well or do they need help to achieve full remission? Every manual of mental health treatment states that the clinician should aim for full remission of symptoms. Allowing some symptoms to persist strongly raises the likelihood of relapse and marginal functioning. Focus on what you as a practitioner can do to achieve full remission when your initial attempts fall short. The best medication combinations will be identified. Effective non-medication treatments will be specified to help your patient when medication alone is not sufficient. Learn a simple pneumonic to help decide the way forward when breakthrough relapse symptoms occur.	Christopher M. Doran, MD Psychiatrist, Private Practice; Englewood CO	1.0 CE hour	75%
5	Pre 9	Body Clock, Diet, Hormones & Metabolism: What their Connection Means for Disease Prevention and Treatment Are you a lark or an owl, and what does this mean for overall health and disease risk? Which matters more for overall healthWHAT you eat or WHEN you eat? Altered biological clocks (circadian rhythms) can greatly disrupt metabolism and hormonal secretions, contributing to related disorders such as type 2 diabetes, metabolic syndrome, obesity, fatty liver, cardiovascular disease, and cancer. Examine the impact of biorhythms, chronotypes, circadian genes, and dietary influences.	Christine Kessler, MN, CNS, ANP, BC-ADM, CDTC, FAANP Founder and Nurse Practitioner, Metabolic Medicine Associates; King George VA	1.5 CE hours	50%
6	A2	Ketamine: Uses and Abuses Initially, Ketamine was primarily used for pediatric procedural sedation. Therapeutic uses have expanded to adult and pediatric patients, pain, rapid sequence intubation, refractory depression, refractory neuropathic pain, and more. Learn how ketamines mechanism of action provides benefit to patients in such different disease states. It is also important to be aware of the potential for ketamine abuse, how to monitor for such abuse, and why ketamine may be abused. Therapeutic uses of ketamine, including the different doses for different therapies will be discussed, as well as monitoring for potential adverse effects, and the potential ways to abuse ketamine.	Nancy Balch, PharmD, BCCCP Emergency Medicine Pharmacist, In-patient Pharmacy, Massachusetts General Hospital; Boston MA	1.5 CE hours	100%
7	KN	How Nurse Practitioners Can Improve Health Equity Hear from the study director on the Institute of Medicines report, The Future of Nursing: Leading Change, Advancing Health. Dr. Hassmiller will discuss how nurse practitioners are helping to advance health equity in the wake of the COVID-19 pandemic. There are expanded roles and opportunities for nurses and nurse practitioners. Additionally, the nursing field can help to ensure that everyone has a fair and just opportunity for health.	Susan B. Hassmiller, RN, PhD, FAAN Senior Advisor for Nursing, Robert Wood Johnson Foundation; Princeton NJ	1.0 CE hour	0%
8	B1	Adverse Childhood Events: Genetic Impacts and Risks for Adult Disease Since the landmark 1998 Adverse Childhood Event (ACEs) study from the Centers for Disease Control and Prevention and Kaiser Permanente, a paradigm shift has occurred in the healthcare approach to adult disease. Evidence is emerging to demonstrate how complex trauma can impact a persons biology and genetic composition. ACEs are now recognized as a significant contributor to adverse holistic health outcomes, including predisposition to risk of depression, heart disease, overweight/obesity, asthma, cancer, and many others. Explore the health impacts of ACEs and understand how to foster protective factors and resilience in a trauma-informed and culturally-responsive way.	Jessica Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN Clinical Professor, Louise Herrington School of Nursing, Baylor University; Dallas TX and Certified Pediatric Nurse Practitioner, Primary Care, League City Pediatrics, League City TX	1.5 CE hours	0%
9	C5	Viral Rashes: New and Old Although immunizations are available for many viral conditions, with the current pandemic adults and children are falling behind on scheduled immunizations. Therefore, the differential diagnosis of rashes now includes viral exanthems previously not seen for many years. Not all rashes pose a threat to the community and many do not require isolation. Learn how to recognize and treat all rashes appropriately.	Peggy Vernon, RN, MA, C-PNP, DCNP, FAANP Owner/Dermatology Nurse Practitioner, Creekside Skin Care; Greenwood Village CO	1.5 CE hours	50%
10	D3	Syphilis: The Return of a Supervillain Syphilis is a preventable infection that causes serious morbidity and mortality. Rates have been increasing in the United States for the last decade after several decades of decline. Providers should be aware of the latest trends and how to decrease the disease burden in their patient populations. The most common methods of syphilis transmission between people, including congenital infections will be discussed. Explore methods of testing, ways to prevent infection, and the most up to date treatment regimens.	Alison Marshall, RN, MSN, FNP-C Faculty, Sylvie Ratele STD/HIV Prevention Training Center of New England, Massachusetts Department of Health; Jamaica Plain MA and Assistant Director and Clinical Instructor, FNP Program, William F. Connell School of Nursing, Boston College; Chestnut Hill MA	1.5 CE hours	50%
11	E6	New Ideas for Old Conversations: Discussing Advance Directives Discussing advance directives is one of the most important conversations that clinicians will ever have with their patients. It is a myth that advance directive discussions are only for the elderly. COVID has pushed to the forefront our awareness and implementation of advance directives discussions. There are many tools that clinicians can utilize to help facilitate these challenging discussions, involving for the patient their clinical, cultural, financial, and extended family issues. Learn strategies to overcome obstacles with these discussions.	Martha Moneypenny, FNP, GNP, ANP-BC, HPNA-BC Nurse Practitioner, Optum; Phoenix AZ	1.5 CE hours	0%
12	CIC	Challenges in Care: What Have We Learned From COVID-19? What are the obligations of NPs in the pandemic? What factors contribute to our moral distress? What choices have we made in prioritizing vaccinations in the roll out? How do we balance individual needs versus public health needs? Should COVID-19 vaccinations be mandated? What are our obligations to the rest of the world? The Challenges in Care panel will tackle these issues and more in a lively audience-interactive session.	Jean Abbott, MD, MH Faculty, Center for Bioethics & Humanities, University of Colorado Anschutz Medical Campus; Aurora CO Nancy Rudner, DrPH, MPH, MSN, APRN Nurse Practitioner, Family Physicians Group; Orlando FL and Associate Professor, School of Nursing, University of Alabama at Birmingham; Birmingham AL	1.5 CE hours	0%
13	F1	Choosing Wisely National APRN Collaborative High-value healthcare focuses on improvements to produce cost effective care, however limited information on the role of advanced practice registered nurses (APRNs) exists. An APRN national collaborative focuses on developing and implementing high-value care initiatives. Monthly calls, podcasts, and a ?le sharing platform are used to facilitate the work of the national collaborative. A total of 16 APRN teams from 14 states are participating and have implemented a number of initiatives to reduce unnecessary testing and treatments, promote appropriate antibiotic use, and promote optimal clinical practices, such as mobility for hospitalized elderly patients, among others. Hear strategies for implementing initiatives to showcase the impact of the APRN role, based on a national collaborative, which has proven to be a successful way to engage APRN teams to focus on targeting high-value care and promoting evidence-based practices in clinical care.	April Kapu, DNP, APRN, ACNP-BC Associate Chief Nursing Officer and Director for Advanced Practice, Center for Nursing Excellence, Vanderbilt University Medical Center; Nashville TN, Assistant in Critical Care, Department of Anesthesiology, School of Medicine and Associate Professor, School of Nursing, Vanderbilt University; Nashville TN Ruth Kleinpell, PhD, RN, FAAN, FCCM Associate Dean for Clinical Scholarship, Independence Foundation Chair for Nursing Education, and Professor, School of Nursing, Vanderbilt University; Nashville TN and Professor, College of Nursing, Rush University; Chicago IL	1.0 CE hour	0%
14	G1	Advanced Practice Leadership Panel In 2007 there were an estimated 120,000 licensed NPs in 2017 the number had more than doubled to 234,000. As the numbers grow, a vacuum in leadership has developed. In large organizations there may be non-APRN supervisors who do not understand the role of advance practice providers. This can lead to issues with defined roles, credentialing, understanding of scope of practice, and lack of shared governance. At the core of every strong Advanced Practice Provider team, youll nearly always find a strong Advanced Practice Provider leader. The interest in leadership has grown as more NPs recognize the positive impact that having a spot at the leadership table has on the organizations view and use of the NP role. Learn why creating competencies and developing NPs in leadership roles is more important now than ever before, and hear recommendations from current NP leaders on steps you can take to advance your role.	Amanda Chaney, DNP, APRN, FAANP, AF-AASLD Chair, Advanced Practice Providers Subcommittee and Nurse Practitioner, Liver Transplant/Hepatology Hospital Medicine, Mayo Clinic; Jacksonville FL April Kapu, DNP, APRN, ACNP-BC Associate Chief Nursing Officer and Director for Advanced Practice, Center for Nursing Excellence, Vanderbilt University Medical Center; Nashville TN, Assistant in Critical Care, Department of Anesthesiology, School of Medicine and Associate Professor, School of Nursing, Vanderbilt University; Nashville TN Ruth Kleinpell, PhD, RN, FAAN, FCCM Associate Dean for Clinical Scholarship, Independence Foundation Chair for Nursing Education, and Professor, School of Nursing, Vanderbilt University; Nashville TN and Professor, College of Nursing, Rush University; Chicago IL Jennifer Rodgers, DNP, APRN, ACNP-BC, FAANP Vice President, Advanced Practice and Associate Chief Nursing Officer, Ambulatory Nursing, UCHealth University of Colorado Hospital; Aurora CO and Assistant Professor, Pulmonary & Critical Care Division, School of Medicine, University of Colorado Anschutz Medical Campus; Aurora CO Laura Thomas, DNP, APRN-BC, WHNP-BC Director, Womens Services, The Medical Center of Aurora; Aurora CO	1.5 CE hours	0%
15	H3	New ASCCP Guidelines and App The 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors was published in April 2020. Hear a review of the revised guidelines and a framework for incorporating new data and technologies. Guiding principles will be outlined using specific clinical situations showing how to incorporate the ASCCP Management Guidelines App into clinical practice. Discussion of cervical dysplasia and colposcopy guidelines will be included.	Kristina M. Tocce, MD, MPH Vice President and Medical Director, Planned Parenthood of the Rocky Mountains; CO, NM, NV, WY and Volunteer Clinical Faculty Member, Department of OB/GYN, School of Medicine, University of Colorado Anschutz Medical Campus; Aurora CO	.75 CE hour	0%
16	J1	Swimming Upstream on Omega-3 Recommendations for Cardiovascular Health: New Research Finds Existing Recommended Dosage May Not Be Enough New research based on a meta-analysis of 40 clinical studies finds that omega-3 intake is associated with significant improvements in risk reduction for certain cardiovascular events, and that the benefits appear to increase with dosage. However, intake of EPA+DHA omega-3s remains far below recommendations, with intake displaced by less potent plant-based omega-3 sources or other fats. Hear more about the research and what it means for preventative health.	Robyn Kievit, FNP-BC, RDN, LDN, CSSD, CEDRD Certified Specialist in Sports Dietetics and Certified Eating Disorders Registered Dietitian, Private Practice; Concord MA Carl (Chip) J. Lavie, Jr., MD, FACC, FACP, FCCP Medical Director, Cardiac Rehabilitation and Prevention and Director, Cardiology Education - Internal Medicine Training Program; Ochsner Foundation Hospital and Clinic; New Orleans LA	1.5 CE hours	0%
17	L4	Winning Strategies and Messaging for Improving Access to Care The Center to Champion Nursing in America, a joint initiative of AARP Foundation, AARP and the Robert Wood Johnson Foundation, has created strategies to help state-based coalitions secure policy wins. Use of message development, delivery and coalition building will be explained. Hear examples of how these strategies helped achieve state and federal policy wins. Stakeholder organizations who are, or would like to be, involved in APRN scope of practice advocacy work will also be discussed.	Winifred V. Quinn, PhD, FAANP (Hon) Director, Advocacy & Consumer Affairs, Center to Champion Nursing in America, AARP; Washington DC	1.5 CE hours	0%
18	M5	ARDS and Ventilator Induced Lung Injuries Over half of all patients admitted to the intensive care unit require ventilatory support. While mechanical ventilation can be life-saving, it can also cause harm by injuring the lungs. Hear about the pathophysiology of ventilator induced lung injury and strategies to prevent it. Discussion of Acute Respiratory Distress Syndrome (ARDS) guidelines will be included, along with special emphasis on ventilator management in the context of COVID-19 pneumonia.	William J. Janssen, MD Section Head, Critical Care Medicine, National Jewish Health; Denver CO	1.0 CE hour	0%
19	N1	Diabetes Mellitus Diabetes Mellitus affects 34 million people in the United States and is the leading cause of kidney failure, acquired blindness, and non-traumatic amputations in this country. Type 1 Diabetes is an autoimmune disease in which the immune system destroys pancreatic beta cells resulting in absolute insulin deficiency, while the pathophysiology of type 2 diabetes involves a complex interplay between excessive hepatic glucose production, tissue insulin resistance, and insulin deficiency. Maintaining good glucose control can prevent the chronic complications of diabetes. Several diabetes medications have also been shown to have highly beneficial effects on co-morbidities such as cardiovascular disease, heart failure and chronic kidney disease. Case discussions will be used to illustrate personalized decision making regarding glycemic targets and therapeutic choices for individual diabetes patients.	Michael T. McDermott, MD Director, Endocrinology and Diabetes Practice, University of Colorado Hospital and Professor of Medicine and Clinical Pharmacy, Division of Endocrinology, Metabolism and Diabetes, School of Medicine, University of Colorado Anschutz Medical Campus; Aurora CO	1.5 CE hours	75%
20	O2	Epilepsy, Seizures and Faints Concentrate on the differential diagnosis of loss of consciousness with special attention on historical facts necessary to best differentiate seizures from other causes of loss of consciousness. Seizures and epilepsy will be discussed, incorporating a logical approach to seizure classification. Hear how to track recurrence and discuss driving restrictions, along with the need for antiepileptic medication and how each of the anticonvulsants is best utilized.	Bruce Morgenstern, MD Neurologist, Blue Sky Neurology; Lone Tree CO	1.5 CE hours	25%
21	P5	Cytokine Release Syndrome: What Is It Really? Cytokine Release Syndrome (CRS) has become a common phrase used in everyday conversation since the onset of Coronavirus Disease 2019 (COVID-19). But the syndrome is not new and is thought to have contributed to the lethal outcomes of the 1918-1919 influenza pandemic. CRS and cytokine storm are terms that describe a lifethreatening inflammatory response in the body that results in increased circulating levels of cytokines and hyperactivation of immune cells. There are many triggers to this reaction including medical therapies, pathogens and cancers. The high levels of cytokines lead to a dysregulation of the immune system and its protective mechanisms causing multisystem organ failure. It is imperative that nurse practitioners are able to identify CRS early and initiate interventions to lessen the deadly impact of this immune dysregulation. Review the pathophysiologic features, clinical features, and possible interventions that may improve patient outcomes.	Nancy Munro, RN, MN, CCRN, ACNP-BC, FAANP Senior Acute Care Nurse Practitioner, Critical Care Medicine Department and Pulmonary Consult Service, National Institutes of Health; Bethesda MD and Faculty Associat	1.5 CE hours	50%
22	R4	Concepts of Pediatric Urology Learn about common conditions treated within pediatric urology, and likely encountered in primary care, family medicine, and/or urgent care. Diagnosis and management of voiding dysfunction and bed wetting will be presented, including an in-depth analysis how to distinguish enuresis, afebrile UTIs, and incomplete bladder emptying. Explore the indications and techniques of newborn circumcisions, along with how to clarify cultural/medical indications. Undescended testicles are also commonly encountered and require a nuanced exam and knowledge of treatment timelines.	Brian Miller, PA-C Lead Advanced Practice Provider, Pediatric Urology, Department of Surgery, University of Colorado Hospital; Aurora CO	1.0 CE hour	25%

ON-DEMAND ENCORE VIRTUAL SESSIONS

The On-demand Encore Virtual Sessions offer greater flexibility for individual circumstances. The On-demand Encore Virtual Sessions consist of recorded accredited sessions from the live meeting. Take in the sessions 24/7 virtually from your workplace, comfort of your home or any other place of your choosing, starting July 15, 2021 and continuing through December 1, 2021. Registrants can participate in On-demand Encore Virtual Sessions on an a-la-carte basis, or bundle them as a package.

Notes:

You can register for the On-demand Encore Virtual Sessions (a-la-carte or package) without attending the live meeting in-person.
If you attend the live meeting in-person, and select the a-la-carte add-on option, the first 6 On-demand Encore Virtual Sessions are complimentary, with additional sessions at $25 per session.
CE hours are not allowed to be awarded for duplicate session(s) previously attended at the live meeting in-person.
You do not need to complete everything in one sitting.You can return anytime through and including December 1, 2021 to view additional sessions and/or take tests.
80% correct is considered passing for the 6-question test.

Presentation #1 (Pre 2) – Dermatology Conundrums: Interesting Cases
(1.5 CE hours, including 0.75 Rx hour)
Click here to view accreditation statement
Click here to view the presentation video
Click here to take the test

Presentation #2 (Pre 3) – Hereditary Cancer Risk Assessment and Testing: Evolving Guidelines, Updates and Resources to Support Identification and Management of Patients at Risk
(1.5 CE hours, including 0.0 Rx hours)
Click here to view accreditation statement
Click here to view the presentation video
Click here to take the test

Presentation #3 (Pre 5) – Primary to Acute Care Palliative Care Transitions
(1.0 CE hour, including 0.0 Rx hours)
Click here to view accreditation statement
Click here to view the presentation video
Click here to take the test

Presentation #4 (Pre 7) – Partially Responsive Depressed Patient
(1.0 CE hour, including 0.75 Rx hour)
Click here to view accreditation statement
Click here to view the presentation video
Click here to take the test

Presentation #5 (Pre 9) – Body Clock, Diet, Hormones & Metabolism: What their Connection Means for Disease Prevention and Treatment
(1.5 CE hours, including 0.75 Rx hour)
Click here to view accreditation statement
Click here to view the presentation video
Click here to take the test

Presentation #6 (A2) – Ketamine: Uses and Abuses
(1.5 CE hours, including 1.5 Rx hours)
Click here to view accreditation statement
Click here to view the presentation video
Click here to take the test

Presentation #7 (KN) – How Nurse Practitioners Can Improve Health Equity
(1.0 CE hour, including 0.0 Rx hours)
Click here to view accreditation statement
Click here to view the presentation video
Click here to take the test

Presentation #8 (B1) – Adverse Childhood Events: Genetic Impacts and Risks for Adult Disease
(1.5 CE hours, including 0.0 Rx hours)
Click here to view accreditation statement
Click here to view the presentation video
Click here to take the test

Presentation #9 (C5) – Viral Rashes: New and Old
(1.5 CE hours, including 0.75 Rx hour)
Click here to view accreditation statement
Click here to view the presentation video
Click here to take the test

Presentation #10 (D3) – Syphilis: The Return of a Supervillain
(1.5 CE hours, including 0.75 Rx hour)
Click here to view accreditation statement
Click here to view the presentation video
Click here to take the test

Presentation #11 (E6) – New Ideas for Old Conversations: Discussing Advance Directives
(1.5 CE hours, including 0.0 Rx hours)
Click here to view accreditation statement
Click here to view the presentation video
Click here to take the test

Presentation #12 (CIC) – Challenges in Care: What Have We Learned From COVID-19?
(1.5 CE hours, including 0.0 Rx hours)
Click here to view accreditation statement
Click here to view the presentation video
Click here to take the test

Presentation #13 (F1) – Choosing Wisely National APRN Collaborative
(1.0 CE hour, including 0.0 Rx hours)
Click here to view accreditation statement
Click here to view the presentation video
Click here to take the test

Presentation #14 (G1) – Advanced Practice Leadership Panel
(1.5 CE hours, including 0.0 Rx hours)
Click here to view accreditation statement
Click here to view the presentation video
Click here to take the test

Presentation #15 (H3) – New ASCCP Guidelines and App
(0.75 CE hour, including 0.0 Rx hours)
Click here to view accreditation statement
Click here to view the presentation video
Click here to take the test

Presentation #16 (J1) – Swimming Upstream on Omega-3 Recommendations for Cardiovascular Health: New Research Finds Existing Recommended Dosage May Not Be Enough
(1.5 CE hours, including 0.0 Rx hours)
Click here to view accreditation statement
Click here to view the presentation video
Click here to take the test

Presentation #17 (L4) – Winning Strategies and Messaging for Improving Access to Care
(1.5 CE hours, including 0.0 Rx hours)
Click here to view accreditation statement
Click here to view the presentation video
Click here to take the test

Presentation #18 (M5) – ARDS and Ventilator Induced Lung Injuries
(1.0 CE hour, including 0.0 Rx hours)
Click here to view accreditation statement
Click here to view the presentation video
Click here to take the test

Presentation #19 (N1) – Diabetes Mellitus
(1.5 CE hours, including 1.125 Rx hours)
Click here to view accreditation statement
Click here to view the presentation video
Click here to take the test

Presentation #20 (O2) – Epilepsy, Seizures and Faints
(1.5 CE hours, including 0.375 Rx hour)
Click here to view accreditation statement
Click here to view the presentation video
Click here to take the test

Presentation #21 (P5) – Cytokine Release Syndrome: What Is It Really?
(1.5 CE hours, including 0.75 Rx hour)
Click here to view accreditation statement
Click here to view the presentation video
Click here to take the test

Presentation #22 (R4) – Concepts of Pediatric Urology
(1.0 CE hour, including 0.25 Rx hour)
Click here to view accreditation statement
Click here to view the presentation video
Click here to take the test